Skip to main content
PRLD logo

PRLD · Prelude Therapeutics Inc · Held by Funds

Track PRLD — free
$3.23 -0.03 (-0.77%) At close · Nov 20 Play latest call Q3 2025 earnings call transcript
Market Cap
$258.63M
Shares
80.07M
Volume · Nov 20 300.1K Avg daily vol (3M) 434.45K

Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.

Fund Ownership of PRLD by Fund Type

Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026

Index funds and index ETFs hold 4.28% of shares outstanding.

Fund type Of shares outstanding Shares
Index funds 0.55% 441,515
Index ETFs 3.73% 2,983,981
Active ETFs 0.02% 12,085
Active funds 0.52% 414,796
Unclassified 0.02% 13,637
All registered funds 4.83% 3,866,014
How fund types are measured

Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.

Funds holding PRLD

82 fund positions
Fund Balance Value % of Fund Open
Showing 1–50 of 82 positions
Key facts CIK 1678660 CUSIP 74065P101 13F (30d) 104 filings 90 filers Visit website Investor relations